Literature DB >> 9018336

Comparison of ras activation in prostate carcinoma in Japanese and American men.

N Konishi1, Y Hiasa, T Tsuzuki, M Tao, T Enomoto, G J Miller.   

Abstract

BACKGROUND: Comparative studies of point mutations in K-, N-, and H-ras oncogenes were performed on prostate carcinoma from Japanese and American patients to clarify the racial difference.
METHODS: We probed for mutations in 70 Japanese and 31 American specimens using polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis and immunohistochemistry for ras p21.
RESULTS: Within the 70 Japanese specimens, eight mutations in codon 12 of K-ras (five GGT-->GTT transversions and three CGT-->GAT transitions) and one mutation in codon 12 of the N-ras gene (a GGT-->GTT transversion) were confirmed, whereas the American samples yielded only one definable mutation, a GGT-->GAT transition, in codon 12 of K-ras.
CONCLUSIONS: The frequency of ras gene mutations in clinical carcinoma in Japanese men was higher than that in American men. It is suggested that there may be fundamental differences in the etiology of prostate carcinoma in Japan and the United States, perhaps based on genetics and/or environmental factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018336     DOI: 10.1002/(sici)1097-0045(19970101)30:1<53::aid-pros8>3.0.co;2-m

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

1.  Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations.

Authors:  P Rieske; J Bartkowiak; A Szadowska; M Debiec-Rychter
Journal:  Mol Pathol       Date:  1999-04

2.  Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas.

Authors:  Fatma Silan; Yener Gultekin; Sinem Atik; Davran Kilinc; Cabir Alan; Fazilet Yildiz; Ahmet Uludag; Ozturk Ozdemir
Journal:  Mol Biol Rep       Date:  2011-05-24       Impact factor: 2.316

3.  Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells.

Authors:  Clay L Efferson; Naotake Tsuda; Kouichiro Kawano; Estanislao Nistal-Villán; Shankhar Sellappan; Dihua Yu; James L Murray; Adolfo García-Sastre; Constantin G Ioannides
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.

Authors:  Seung-Keun Hong; Joseph H Jeong; Andrew M Chan; Jong-In Park
Journal:  Exp Cell Res       Date:  2013-05-20       Impact factor: 3.905

5.  The genomic landscape of prostate cancer.

Authors:  Sylvan C Baca; Levi A Garraway
Journal:  Front Endocrinol (Lausanne)       Date:  2012-05-16       Impact factor: 5.555

6.  Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as a prognostic marker.

Authors:  S J Chia; W Y Tang; J Elnatan; W M Yap; H S Goh; D R Smith
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

Review 7.  The molecular basis for ethnic variation and histological subtype differences in prostate cancer.

Authors:  Yang Zong; Andrew S Goldstein; Jiaoti Huang
Journal:  Sci China Life Sci       Date:  2013-07-13       Impact factor: 6.038

8.  BRAF activation initiates but does not maintain invasive prostate adenocarcinoma.

Authors:  Joseph H Jeong; Zhenxiong Wang; Alexander S Guimaraes; Xuesong Ouyang; Jose L Figueiredo; Zhihu Ding; Shan Jiang; Isil Guney; Gyeong Hoon Kang; Eyoung Shin; William C Hahn; Massimo F Loda; Cory Abate-Shen; Ralph Weissleder; Lynda Chin
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240

9.  Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.

Authors:  Man Kit Siu; Wassim Abou-Kheir; Juan Juan Yin; Yung-Sheng Chang; Ben Barrett; Florent Suau; Orla Casey; Wei-Yu Chen; Lei Fang; Paul Hynes; Yao-Yu Hsieh; Yen-Nien Liu; Jiaoti Huang; Kathleen Kelly
Journal:  Oncotarget       Date:  2014-06-15

Review 10.  Prostate cancer in East Asia: evolving trend over the last decade.

Authors:  Yao Zhu; Hong-Kai Wang; Yuan-Yuan Qu; Ding-Wei Ye
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.